Education
About Us
Working with TipRanks
Follow Us
EVE Health Group Limited (AU:EVE)
ASX:EVE
EVE Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.04
Previous CloseN/A
Volume9.81K
Average Volume (3M)774.07K
Market Cap
AU$5.70M
Enterprise ValueAU$3.70M
Total Cash (Recent Filing)AU$903.42K
Total Debt (Recent Filing)AU$91.28K
Price to Earnings (P/E)―
Beta0.22
Next Earnings
Mar 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding284,876,600
10 Day Avg. Volume491,958
30 Day Avg. Volume774,070
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.22
Price to Sales (P/S)2.49
P/FCF Ratio-2.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Equity BaseA very low debt-to-equity ratio and stable equity base reduce financial risk and provide durable balance-sheet flexibility. This conservatism lowers bankruptcy risk and preserves capacity to fund restructuring, product investment or working capital over several quarters without heavy interest burdens.
Improving Free Cash Flow TrendImprovement in free cash flow growth and a FCF-to-net-income ratio of ~1.0 indicate the company is starting to convert accounting results into cash. Sustained FCF expansion underpins the ability to fund operations or modest investments internally and reduces reliance on external financing over the medium term.
Gross Margin ImprovementRising gross margins point to better input-cost management or pricing execution. If sustained, improved gross economics create room to absorb SG&A and fixed costs, and are the first durable step toward restoring operating profitability and strengthening long-term margin sustainability.
Bears Say
Declining RevenueA double-digit revenue decline erodes scale and limits ability to spread fixed costs, making margin recovery harder. Continued top-line contraction increases execution risk for any turnaround, reduces bargaining power with suppliers, and narrows options to restore sustainable profitability over coming quarters.
Negative Operating Cash FlowNegative operating cash flow means core operations are not self-funding, forcing dependence on financing or asset sales. This undermines operational durability and constrains reinvestment in growth or margin-restoring initiatives unless negative OCF is reversed within a medium-term timeframe.
Persistent UnprofitabilitySustained negative net and operating margins indicate the business is not generating operating returns, which erodes shareholder equity and limits reinvestment. Without a credible path to positive EBIT/EBITDA, the company faces constrained strategic options and weaker investor confidence over months.
EVE Health Group Limited News
EVE FAQ
What was EVE Health Group Limited’s price range in the past 12 months?
EVE Health Group Limited lowest share price was AU$0.02 and its highest was AU$0.04 in the past 12 months.
What is EVE Health Group Limited’s market cap?
EVE Health Group Limited’s market cap is AU$5.70M.
When is EVE Health Group Limited’s upcoming earnings report date?
EVE Health Group Limited’s upcoming earnings report date is Mar 02, 2026 which is in 8 days.
How were EVE Health Group Limited’s earnings last quarter?
EVE Health Group Limited released its earnings results on Aug 29, 2025. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.
Is EVE Health Group Limited overvalued?
According to Wall Street analysts EVE Health Group Limited’s price is currently Overvalued.
Does EVE Health Group Limited pay dividends?
EVE Health Group Limited does not currently pay dividends.
What is EVE Health Group Limited’s EPS estimate?
EVE Health Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EVE Health Group Limited have?
EVE Health Group Limited has 284,876,600 shares outstanding.
What happened to EVE Health Group Limited’s price movement after its last earnings report?
EVE Health Group Limited reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of EVE Health Group Limited?
Currently, no hedge funds are holding shares in AU:EVE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EVE Health Group Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:EVE Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$7.2K over
the Last 3 Months
the Last 3 Months
Fundamentals
Return on Equity
-60.84%
Trailing 12-Months
Asset Growth
63.49%
Trailing 12-Months
Company Description
EVE Health Group Limited
Eve Health Group Limited, together with its subsidiaries, engages in the production and distribution of nutrition, health, and wellness products in Australia, New Zealand, the Asia Pacific, and North America. It provides organic tea tree oils; and distributes botanical oils, as well as supplies essential oils, hydrosols, extracts, carrier oils, and seed oils. The company also offers organic raw honey and raw honey probiotic concentrates; and contract manufacturing services. In addition, it offers medical nutrition solutions for chronic and lifestyle diseases, including Gluco Smooth for type 2 diabetes that reduces the post-meal blood sugar levels; and dietary interventions. The company was formerly known as EVE Investments Limited. Eve Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.
Technical Analysis
―
Fiji Kava Limited
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―
Forbidden Foods Ltd
―
Options Prices
Currently, No data available
---